Parkinson's Research Community

23andMe’s Parkinson’s Research Community is by far the world’s largest re-contactable deeply phenotyped cohort for Parkinson’s disease research.

New Genetic Associations Found

Over the last decade data from this community has contributed significantly to new insights into Parkinson’s disease. This includes the discovery of 90 genetic variants associated with Parkinson’s disease. These findings give scientists potential pathways for future research and insight into possible new drug targets to treat Parkinson’s. 

New Phenotypes

23andMe researchers have also identified more than 100 phenotypic — or non-genetic traits or characteristics — associations with Parkinson’s. This offers the potential for earlier detection of the disease. 23andMe researchers and our collaborators have also published dozens of papers on Parkinson’s. With our collaborators, we have also opened an online portal to provide qualified Parkinson’s researchers’ access to its aggregate-level, de-identified data.